BioSpace News Archive

Business

Lilly Exploring Sale, IPO of Animal Health Biz

Lilly’s Elanco animal health business is facing increased competition.

October 24, 2017

·

54 min read

Medicenna Solidifies Superkine Platform With Additional U.S. Patent Issuance

Medicenna today announced that the U.S. Patent and Trademark Office issued another patent related to the Company’s Superkine platform. U.S. Patent 9,738,696.

October 24, 2017

·

4 min read

Drug Development

FDA Grants Fast Track Designation to Alzheon’s ALZ-801 Development Program for the Treatment of Alzheimer’s Disease

Alzheon announced that FDA has granted Fast Track designation to its lead clinical investigational drug, ALZ-801, for the treatment of Alzheimer’s disease.

October 24, 2017

·

4 min read

Drug Development

Pain Therapeutics Announces Successful Phase I Clinical Study for PTI-125

PTI-125 is well-tolerated in first-in-human clinical study.

October 24, 2017

·

4 min read

Biotech Beach

Imprimis Launches Surface Pharmaceuticals Subsidiary

Imprimis Pharma today announced it has filed a Form 8-K with the SEC which contains a corporate presentation for its subsidiary, Surface Pharma.

October 24, 2017

·

5 min read

Business

Novartis Could Still Spin Off Alcon, But Not Before 2019

Novartis’ final decision would depend on the unit’s continued sales growth.

October 24, 2017

·

31 min read

Business

3M Delivers Record Third-Quarter Sales and Earnings per Share; Company Increases Full-Year 2017 Outlook

3M today reported third-quarter earnings of $2.33 per share, an increase of 8.4 percent versus the third quarter of 2016. Sales were $8.2 billion, up 6.0 percent year-on-year in dollar terms.

October 24, 2017

·

19 min read

Genetown

Sage Therapeutics to Report Third Quarter 2017 Financial Results on Thursday, November 2, 2017

Sage Therapeutics today announced that the company will host a conference call and live webcast on Thursday, November 2, 2017 at 8:00 am ET to report its third quarter 2017 financial results and to discuss recent business updates.

October 24, 2017

·

1 min read

Business

Sites Medical Licenses its OsteoSync Ti Technology to Integrity Implants for Incorporation into their FlareHawk Family of Expandable Implants

Sites Medical announced it has entered into a licensing agreement with Integrity Implants, to incorporate its proprietary OsteoSync Ti technology into Integrity’s novel multi-dimensional expandable interbody devices.

October 24, 2017

·

3 min read

Pharm Country

Genmab Alums’ YmAbs Raises $50M

The cash enables YmAbs to focus on bringing the company’s lead compound through the final steps of the regulatory pathway towards approval.

October 24, 2017

·

3 min read